| 0 |
THYROXIN BINDING GLOBULIN DECREASED |
1 |
0.3333 |
| 1 |
URTICARIA PRESSURE |
11 |
0.1833 |
| 2 |
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE IV |
1 |
0.0833 |
| 3 |
URTICARIA THERMAL |
11 |
0.0775 |
| 4 |
RENAL ARTERY FIBROMUSCULAR DYSPLASIA |
1 |
0.0455 |
| 5 |
APOCRINE BREAST CARCINOMA |
1 |
0.0400 |
| 6 |
MIGRAINE WITHOUT AURA |
11 |
0.0367 |
| 7 |
STAB WOUND |
11 |
0.0311 |
| 8 |
HEAD DEFORMITY |
9 |
0.0294 |
| 9 |
OVARIAN ENDOMETRIOID CARCINOMA |
1 |
0.0238 |
| 10 |
CYSTOCELE REPAIR |
1 |
0.0233 |
| 11 |
LACK OF INFUSION SITE ROTATION |
1 |
0.0208 |
| 12 |
RECTOCELE REPAIR |
1 |
0.0169 |
| 13 |
BORDERLINE OVARIAN TUMOUR |
1 |
0.0149 |
| 14 |
INJECTION SITE SCAB |
11 |
0.0114 |
| 15 |
KIDNEY ENLARGEMENT |
11 |
0.0101 |
| 16 |
EYELID RETRACTION |
1 |
0.0100 |
| 17 |
CHRONIC SPONTANEOUS URTICARIA |
11 |
0.0095 |
| 18 |
SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED |
1 |
0.0076 |
| 19 |
SINUS RHYTHM |
3 |
0.0069 |
| 20 |
CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
1 |
0.0068 |
| 21 |
ENLARGED CLITORIS |
1 |
0.0061 |
| 22 |
ADHESIVE TAPE USE |
2 |
0.0052 |
| 23 |
SCHIZOAFFECTIVE DISORDER |
7 |
0.0039 |
| 24 |
HEPATIC TRAUMA |
1 |
0.0039 |
| 25 |
CORONARY ARTERY EMBOLISM |
1 |
0.0034 |
| 26 |
ADNEXAL TORSION |
1 |
0.0032 |
| 27 |
SECONDARY HYPOGONADISM |
1 |
0.0030 |
| 28 |
INTRACRANIAL PRESSURE INCREASED |
16 |
0.0029 |
| 29 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 30 |
PRODUCT INEFFECTIVE |
2 |
0.0025 |
| 31 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
4 |
0.0025 |
| 32 |
SPLENIC ABSCESS |
1 |
0.0025 |
| 33 |
LAGOPHTHALMOS |
1 |
0.0024 |
| 34 |
ANEURYSM |
11 |
0.0022 |
| 35 |
HOMICIDE |
4 |
0.0022 |
| 36 |
CHLOASMA |
1 |
0.0022 |
| 37 |
PRODUCT DOSAGE FORM ISSUE |
1 |
0.0021 |
| 38 |
WATER INTOXICATION |
1 |
0.0020 |
| 39 |
STREPTOCOCCAL INFECTION |
11 |
0.0020 |
| 40 |
BUTTERFLY RASH |
2 |
0.0020 |
| 41 |
SYMPTOM RECURRENCE |
11 |
0.0018 |
| 42 |
ARTHROPOD BITE |
11 |
0.0015 |
| 43 |
LICHEN SCLEROSUS |
1 |
0.0015 |
| 44 |
ONYCHOMADESIS |
6 |
0.0014 |
| 45 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 46 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
2 |
0.0014 |
| 47 |
INFECTED BITE |
1 |
0.0012 |
| 48 |
DEAFNESS TRANSITORY |
1 |
0.0012 |
| 49 |
SLEEP-RELATED EATING DISORDER |
1 |
0.0011 |
| 50 |
TEMPERATURE INTOLERANCE |
11 |
0.0011 |
| 51 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 52 |
JOINT SPRAIN |
1 |
0.0010 |
| 53 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 54 |
AORTIC DILATATION |
1 |
0.0009 |
| 55 |
CARDIOMEGALY |
11 |
0.0009 |
| 56 |
BRAIN OEDEMA |
11 |
0.0009 |
| 57 |
SPLENECTOMY |
1 |
0.0009 |
| 58 |
ASPERGILLOSIS |
1 |
0.0008 |
| 59 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
1 |
0.0008 |
| 60 |
INFUSION SITE RASH |
1 |
0.0007 |
| 61 |
CHOLANGIOCARCINOMA |
1 |
0.0007 |
| 62 |
HYPOSMIA |
1 |
0.0007 |
| 63 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 64 |
MUSCULOSKELETAL DISCOMFORT |
11 |
0.0006 |
| 65 |
SALMONELLOSIS |
1 |
0.0006 |
| 66 |
SPLEEN DISORDER |
1 |
0.0006 |
| 67 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 68 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 69 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 70 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 71 |
BLOOD TESTOSTERONE INCREASED |
1 |
0.0005 |
| 72 |
PRODUCT PRESCRIBING ERROR |
11 |
0.0005 |
| 73 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 74 |
PAPILLOEDEMA |
2 |
0.0004 |
| 75 |
ORAL DISCOMFORT |
6 |
0.0004 |
| 76 |
DRUG LEVEL INCREASED |
7 |
0.0004 |
| 77 |
GASTRITIS |
11 |
0.0004 |
| 78 |
HOSTILITY |
1 |
0.0004 |
| 79 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 80 |
PANCREATIC CARCINOMA METASTATIC |
1 |
0.0004 |
| 81 |
CREPITATIONS |
1 |
0.0003 |
| 82 |
IMPAIRED HEALING |
11 |
0.0003 |
| 83 |
MYELOFIBROSIS |
1 |
0.0003 |
| 84 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 85 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 86 |
LIVER ABSCESS |
1 |
0.0003 |
| 87 |
POLYP |
2 |
0.0003 |
| 88 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 89 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 90 |
EYE SWELLING |
11 |
0.0003 |
| 91 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 92 |
WOUND COMPLICATION |
1 |
0.0003 |
| 93 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 94 |
EATING DISORDER |
6 |
0.0003 |
| 95 |
BLINDNESS |
11 |
0.0003 |
| 96 |
IMPULSIVE BEHAVIOUR |
1 |
0.0003 |
| 97 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 98 |
SNORING |
1 |
0.0003 |
| 99 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 100 |
ANGIOEDEMA |
11 |
0.0002 |
| 101 |
VITAMIN B12 DEFICIENCY |
1 |
0.0002 |
| 102 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 103 |
RENAL DISORDER |
11 |
0.0002 |
| 104 |
INFLAMMATION |
12 |
0.0002 |
| 105 |
HEPATIC LESION |
1 |
0.0002 |
| 106 |
LUNG DISORDER |
11 |
0.0002 |
| 107 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 108 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 109 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 110 |
OXYGEN SATURATION DECREASED |
12 |
0.0002 |
| 111 |
ERYSIPELAS |
1 |
0.0002 |
| 112 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 113 |
ELECTROCARDIOGRAM QT PROLONGED |
7 |
0.0002 |
| 114 |
BONE PAIN |
11 |
0.0002 |
| 115 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 116 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 117 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 118 |
SLEEP APNOEA SYNDROME |
3 |
0.0002 |
| 119 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 120 |
HERPES SIMPLEX |
1 |
0.0002 |
| 121 |
SOMNAMBULISM |
1 |
0.0002 |
| 122 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 123 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 124 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 125 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 126 |
DUODENAL ULCER |
1 |
0.0001 |
| 127 |
ARTHRITIS |
11 |
0.0001 |
| 128 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 129 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 130 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 131 |
MIGRAINE |
13 |
0.0001 |
| 132 |
DRUG ABUSE |
11 |
0.0001 |
| 133 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 134 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 135 |
SWELLING |
12 |
0.0001 |
| 136 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 137 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 138 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 139 |
RESPIRATORY TRACT CONGESTION |
2 |
0.0001 |
| 140 |
STENT PLACEMENT |
1 |
0.0001 |
| 141 |
HICCUPS |
1 |
0.0001 |
| 142 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 143 |
AGGRESSION |
6 |
0.0001 |
| 144 |
DRUG USE DISORDER |
1 |
0.0001 |
| 145 |
CARDIAC DISORDER |
11 |
0.0001 |
| 146 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 147 |
ILLNESS |
12 |
0.0001 |
| 148 |
MYOSITIS |
1 |
0.0001 |
| 149 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 150 |
FEELING JITTERY |
2 |
0.0001 |
| 151 |
AFFECT LABILITY |
1 |
0.0001 |
| 152 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 153 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 154 |
CHILLS |
12 |
0.0001 |
| 155 |
SINUS DISORDER |
2 |
0.0001 |
| 156 |
OVARIAN CYST |
1 |
0.0001 |
| 157 |
BURNING SENSATION |
7 |
0.0001 |
| 158 |
JOINT SWELLING |
12 |
0.0001 |
| 159 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 160 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 161 |
METASTASES TO LUNG |
1 |
0.0001 |
| 162 |
ABDOMINAL DISTENSION |
9 |
0.0001 |
| 163 |
BREAST CANCER |
8 |
0.0001 |
| 164 |
RASH MACULAR |
3 |
0.0001 |
| 165 |
BLOOD PRESSURE INCREASED |
13 |
0.0001 |
| 166 |
BACTERAEMIA |
1 |
0.0001 |
| 167 |
PRODUCT ADHESION ISSUE |
3 |
0.0001 |
| 168 |
MYALGIA |
14 |
0.0001 |
| 169 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 170 |
PHARYNGITIS |
1 |
0.0001 |
| 171 |
CYST |
1 |
0.0001 |
| 172 |
POISONING |
1 |
0.0001 |
| 173 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 174 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 175 |
ANOREXIA |
1 |
0.0001 |
| 176 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 177 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 178 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 179 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 180 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 181 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 182 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 183 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 184 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
0.0001 |
| 185 |
APATHY |
1 |
0.0001 |
| 186 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 187 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 188 |
HYPERTENSION |
14 |
0.0001 |
| 189 |
URTICARIA |
11 |
0.0001 |
| 190 |
ANKLE FRACTURE |
1 |
0.0001 |
| 191 |
DELUSION |
1 |
0.0001 |
| 192 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 193 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 194 |
PNEUMOTHORAX |
1 |
0.0001 |
| 195 |
OBESITY |
1 |
0.0001 |
| 196 |
CARDIAC FAILURE |
5 |
0.0001 |
| 197 |
VIRAL INFECTION |
2 |
0.0001 |
| 198 |
COMPLETED SUICIDE |
5 |
0.0001 |
| 199 |
GAIT INABILITY |
2 |
0.0001 |
| 200 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 201 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 202 |
FEELING ABNORMAL |
14 |
0.0001 |
| 203 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 204 |
WEIGHT INCREASED |
13 |
0.0001 |
| 205 |
PARANOIA |
1 |
0.0001 |
| 206 |
PYREXIA |
20 |
0.0001 |
| 207 |
SYRINGE ISSUE |
1 |
0.0001 |
| 208 |
EOSINOPHILIA |
1 |
0.0001 |
| 209 |
AMENORRHOEA |
1 |
0.0001 |
| 210 |
INCORRECT DOSE ADMINISTERED |
13 |
0.0001 |
| 211 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 212 |
OEDEMA |
3 |
0.0001 |
| 213 |
ERYTHEMA |
11 |
0.0001 |
| 214 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 215 |
ASTHENIA |
20 |
0.0001 |
| 216 |
GASTRIC ULCER |
1 |
0.0001 |
| 217 |
PROTEINURIA |
1 |
0.0001 |
| 218 |
GLAUCOMA |
1 |
0.0001 |
| 219 |
CHOKING |
1 |
0.0001 |
| 220 |
ALOPECIA |
10 |
0.0001 |
| 221 |
DRUG INTERACTION |
8 |
0.0001 |
| 222 |
PRODUCT USE IN UNAPPROVED INDICATION |
12 |
0.0000 |
| 223 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 224 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 225 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 226 |
COUGH |
13 |
0.0000 |
| 227 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 228 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 229 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 230 |
TOOTH DISORDER |
1 |
0.0000 |
| 231 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 232 |
SNEEZING |
1 |
0.0000 |
| 233 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 234 |
FIBROMYALGIA |
1 |
0.0000 |
| 235 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 236 |
BRONCHITIS |
3 |
0.0000 |
| 237 |
AGEUSIA |
1 |
0.0000 |
| 238 |
CONDITION AGGRAVATED |
12 |
0.0000 |
| 239 |
HAEMATOMA |
1 |
0.0000 |
| 240 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 241 |
DIPLOPIA |
1 |
0.0000 |
| 242 |
EAR INFECTION |
1 |
0.0000 |
| 243 |
PRODUCT USE ISSUE |
7 |
0.0000 |
| 244 |
JAUNDICE |
1 |
0.0000 |
| 245 |
CARDIAC ARREST |
3 |
0.0000 |
| 246 |
DIVERTICULITIS |
1 |
0.0000 |
| 247 |
NECK PAIN |
2 |
0.0000 |
| 248 |
EYE PAIN |
2 |
0.0000 |
| 249 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 250 |
EYE IRRITATION |
2 |
0.0000 |
| 251 |
NEEDLE ISSUE |
1 |
0.0000 |
| 252 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 253 |
MALAISE |
15 |
0.0000 |
| 254 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 255 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 256 |
PRURITUS |
13 |
0.0000 |
| 257 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 258 |
ARTHRALGIA |
14 |
0.0000 |
| 259 |
CATARACT |
2 |
0.0000 |
| 260 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 261 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 262 |
EPILEPSY |
1 |
0.0000 |
| 263 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 264 |
HEAD INJURY |
1 |
0.0000 |
| 265 |
CYSTITIS |
1 |
0.0000 |
| 266 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 267 |
EYE DISORDER |
1 |
0.0000 |
| 268 |
DEVICE DIFFICULT TO USE |
2 |
0.0000 |
| 269 |
DECREASED APPETITE |
7 |
0.0000 |
| 270 |
INSOMNIA |
8 |
0.0000 |
| 271 |
FUNGAL INFECTION |
1 |
0.0000 |
| 272 |
VOMITING |
14 |
0.0000 |
| 273 |
FATIGUE |
23 |
0.0000 |
| 274 |
NIGHTMARE |
1 |
0.0000 |
| 275 |
DELIRIUM |
1 |
0.0000 |
| 276 |
HYPOXIA |
1 |
0.0000 |
| 277 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 278 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 279 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 280 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 281 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 282 |
PANIC ATTACK |
1 |
0.0000 |
| 283 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 284 |
DYSARTHRIA |
1 |
0.0000 |
| 285 |
HOT FLUSH |
2 |
0.0000 |
| 286 |
DYSPNOEA |
15 |
0.0000 |
| 287 |
ACNE |
2 |
0.0000 |
| 288 |
HEADACHE |
16 |
0.0000 |
| 289 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 290 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 291 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 292 |
NAUSEA |
19 |
0.0000 |
| 293 |
PRODUCT DOSE OMISSION ISSUE |
7 |
0.0000 |
| 294 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 295 |
COVID-19 |
4 |
0.0000 |
| 296 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 297 |
THROAT IRRITATION |
1 |
0.0000 |
| 298 |
VISION BLURRED |
3 |
0.0000 |
| 299 |
TINNITUS |
1 |
0.0000 |
| 300 |
OFF LABEL USE |
19 |
0.0000 |
| 301 |
HYPOKALAEMIA |
1 |
0.0000 |
| 302 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 303 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 304 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 305 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 306 |
PAIN |
13 |
0.0000 |
| 307 |
RENAL CANCER |
1 |
0.0000 |
| 308 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 309 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 310 |
DRY EYE |
1 |
0.0000 |
| 311 |
CELLULITIS |
1 |
0.0000 |
| 312 |
FLUID RETENTION |
1 |
0.0000 |
| 313 |
HAEMORRHAGE |
2 |
0.0000 |
| 314 |
DEPRESSED MOOD |
1 |
0.0000 |
| 315 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 316 |
DIARRHOEA |
12 |
0.0000 |
| 317 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 318 |
SEPSIS |
2 |
0.0000 |
| 319 |
PANCYTOPENIA |
1 |
0.0000 |
| 320 |
HYPONATRAEMIA |
1 |
0.0000 |
| 321 |
DEPRESSION |
4 |
0.0000 |
| 322 |
CONVULSION |
1 |
0.0000 |
| 323 |
HERPES ZOSTER |
1 |
0.0000 |
| 324 |
LETHARGY |
1 |
0.0000 |
| 325 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 326 |
DYSPHONIA |
1 |
0.0000 |
| 327 |
PALPITATIONS |
2 |
0.0000 |
| 328 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 329 |
VERTIGO |
1 |
0.0000 |
| 330 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 331 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 332 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 333 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 334 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 335 |
RENAL FAILURE |
2 |
0.0000 |
| 336 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 337 |
SOMNOLENCE |
3 |
0.0000 |
| 338 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 339 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 340 |
DRUG INEFFECTIVE |
19 |
0.0000 |
| 341 |
INFECTION |
2 |
0.0000 |
| 342 |
DYSGEUSIA |
1 |
0.0000 |
| 343 |
EPISTAXIS |
1 |
0.0000 |
| 344 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 345 |
BACK PAIN |
3 |
0.0000 |
| 346 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 347 |
PNEUMONIA |
4 |
0.0000 |
| 348 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 349 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 350 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 351 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 352 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 353 |
BALANCE DISORDER |
1 |
0.0000 |
| 354 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 355 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 356 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 357 |
CHEST PAIN |
2 |
0.0000 |
| 358 |
WEIGHT DECREASED |
3 |
0.0000 |
| 359 |
ANXIETY |
3 |
0.0000 |
| 360 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 361 |
ANAEMIA |
2 |
0.0000 |
| 362 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 363 |
SYNCOPE |
1 |
0.0000 |
| 364 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 365 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 366 |
SINUSITIS |
1 |
0.0000 |
| 367 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 368 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 369 |
OVERDOSE |
2 |
0.0000 |
| 370 |
CONSTIPATION |
2 |
0.0000 |
| 371 |
INFLUENZA |
1 |
0.0000 |
| 372 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 373 |
ASTHMA |
1 |
0.0000 |
| 374 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 375 |
SEIZURE |
1 |
0.0000 |
| 376 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 377 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 378 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 379 |
PSORIASIS |
1 |
0.0000 |
| 380 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 381 |
NEUTROPENIA |
1 |
0.0000 |
| 382 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 383 |
HYPOAESTHESIA |
1 |
0.0000 |
| 384 |
HOSPITALISATION |
1 |
0.0000 |
| 385 |
PARAESTHESIA |
1 |
0.0000 |
| 386 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 387 |
TREMOR |
1 |
0.0000 |
| 388 |
DIZZINESS |
3 |
0.0000 |
| 389 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 390 |
MUSCLE SPASMS |
1 |
0.0000 |
| 391 |
HYPOTENSION |
1 |
0.0000 |
| 392 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 393 |
FALL |
1 |
0.0000 |
| 394 |
DEATH |
2 |
0.0000 |